Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Nanostring_nCounter_BreastCancer360

ABSTRACT: hormone receptor-positive early breast cancer by Nanostring BC360 panel

PROVIDER: EGAD00010001994 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

Molecular characterization of Georgia cohort of primary breast cancer FFPE tissues on custom breast cancer DASL panel

Project description:Analysis of 143 formalin-fixed, paraffin-embedded (FFPE) primary breast tumors using a Custom Breast Cancer Panel and Human Cancer Panel for the DASL platform. Molecular markers between the pathology defined subtypes of breast cancer were assessed to hypothesize potential therapeutic targets specific to the subtypes Molecular Characterization of 143 primary breast carcinomas including 101 triple negative (TN: ER-, PR-, HER2-), 3 HER2-positive (HER2+: ER-, PR-, HER2+), and 39 hormone receptor-positive (HR+: ER+ and/or PR+)

2009-10-23 | E-GEOD-18539 | biostudies-arrayexpress

Molecular characterization of Quebec Cohort of Primary Breast Cancer FFPE Tissues on the Human Cancer Panel

Project description:Analysis of 97 formalin-fixed, paraffin-embedded (FFPE) primary breast tumors using Illumina DASL microarray technology on a Custom Breast Cancer Panel and the Illumina Human Cancer Panel. Molecular markers between the pathology defined subtypes of breast cancer were assessed to hypothesize potential therapeutic targets specific to the subtypes Molecular Characterization of 97 primary breast tumor formalin-fixed, paraffin-embedded (FFPE) specimens including 24 triple negative (TN: ER-, PR-, HER2-), 9 HER2-positive (HER2+: ER-, PR-, HER2+), and 64 hormone receptor-positive (HR+: ER+ and/or PR+). 91 of the 97 specimens were characterized on the Illumina Human Cancer DASL Panel and 86 of 97 specimens were characterized on a custom Breast Cancer DASL Panel, 80 of these specimens were common to both the Human Cancer DASL Panel and the custom Breast Cancer DASL Panel.

2009-10-23 | E-GEOD-17650 | biostudies-arrayexpress

Homo sapiens

Project description:Preoperative short-term hormone therapy for hormone receptor positive breast cancer

| PRJNA317765 | ENA

miRNA profile of single hormone receptor positive breast cancer patients

Project description:miRNA profile of single hormone receptor positive breast cancer patients

| PRJNA649524 | ENA

Anti-cancer action of imidazopyridine BAG1 compounds in steriod hormone receptor-positive breast and prostate cancer

Project description:Transcriptomics analyses to study the effect of the imidazopyridine X15695 on proliferation of estrogen receptor positive (ER+) breast and androgen receptor positive (AR+) prostate cancer cells. The effect of X15695 was analyzed on vehicle or steroid hormone-treated breast and prostate cancer cells.

2023-03-13 | GSE218556 | GEO

Discovery cohort for SET ER/PR

Project description:Samples from hormone-receptor positive breast cancer to identify transcripts related to ESR1 and PGR expression.

2019-05-30 | GSE129551 | GEO

Transcriptional analysis of 12 breast cancer patients

Project description:Targeted gene expression on 12 breast cancer patients using the human panCancer Immune panel (NanoString Technologies)

2022-02-09 | GSE180370 | GEO

NanoString PanCancer Immune Panel in Black and White Breast Cancer Patients in the Women's Circle of Health Study (WCHS)

Project description:NanoString PanCancer Immune Panel with customized codesets from a total of 367 Black and White breast cancer patients in WCHS

2020-12-18 | GSE163418 | GEO

Gene expression analysis of treatment-naïve hormone receptor-positive metastistic breast cancer

Project description:Gene expression analysis of treatment-naïve hormone receptor-positive metastistic breast cancer

| PRJNA551385 | ENA

Gene expression analysis of previously treated hormone receptor-positive metastatic breast cancer

Project description:Gene expression analysis of previously treated hormone receptor-positive metastatic breast cancer

| PRJNA527860 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data